Back to news
Daily Market Briefing · 21 November 2026

CMS Proposes Broad Medicare Advantage Overhaul for 2028

The plan would change quality bonuses, food benefits, market-entry rules and selected-state payment tests across a program serving more than 35 million Americans.

Competition and benefit design

The Centers for Medicare & Medicaid Services proposed policy changes for Medicare Advantage and Part D contracts beginning in 2028. CMS says more than 35 million people use Medicare Advantage. The rule would move the network-adequacy review for new plans from the application stage to their first operating year, lowering one barrier to entry while retaining subsequent compliance requirements.[1][2]

CMS also proposed a uniform standard for supplemental food benefits, generally requiring whole, nutrient-dense products consistent with federal dietary guidelines. Provider-recommended products could remain eligible for specific medical needs. The agency said chronically ill enrollees used the relevant food-and-produce benefit nearly 40 million times in 2025, illustrating that the change concerns a material benefit category rather than a symbolic nutrition program.[1]

Quality payments and a ten-year test

The proposal would streamline the Star Ratings system and alter the mechanism that determines quality bonuses. CMS’s regulatory analysis estimates that the ratings changes could save the Medicare Trust Fund $106.96 billion from 2028 through 2037. That is a modelled federal estimate, not guaranteed savings; actual results will depend on plan behavior, enrollment, litigation and the final rule.[2]

A separate mandatory ADVaNCE MA model would begin in 2029 in selected states and run for ten years. It would test risk-adjustment methods, quality incentives and the targeting of supplemental benefits to low-income enrollees. The states had not been named at cutoff, and state Medicaid directors would have a defined opt-out mechanism for certain dual-eligible plans.[1][2]

Administrative consequences and next steps

Other provisions would combine several behavioral-health specialties for network-adequacy purposes, expand recognition of telehealth and change the treatment of selected Part B drugs subject to negotiated maximum prices. Plans would face new encounter-data and executive-certification duties for those drugs. These measures could reduce some enrollment barriers while creating new data, systems and compliance costs.[1][2]

The document is a proposal, not current insurance law. It remains open for public comment for 60 days following Federal Register publication, and CMS can revise or abandon individual provisions. Insurers, providers and investors therefore need to separate the estimated payment effects in the regulatory analysis from rules that have actually been finalized.[1][2]

Sources & evidence

  1. CMS Proposes Reforms to Strengthen Competition, Elevate Care Quality, and Expand Beneficiary Choice in Medicare Advantage (opens in a new tab)
    Centers for Medicare & Medicaid ServicesSource language en

    Program scope, nutrition standard, market-entry, behavioral-health and model proposals.

    Source note

    Public agency release; policy benefits described by CMS are the agency’s stated objectives.

  2. Contract Year 2028 Policy and Technical Changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program (opens in a new tab)
    Federal Register / Centers for Medicare & Medicaid ServicesSource language en

    Regulatory text, projected Star Ratings savings, drug-data requirements and ADVaNCE MA model.

    Source note

    Public-inspection PDF; lengthy technical document was searched and relevant sections were read.